The story of Sildenafil presents a complex picture for investors. While the initial introduction generated substantial profits, the expiration of its exclusive rights opened the door to generic versions, dramatically https://redhotbookmarks.com/story21587269/sildenafil-and-pharma-a-risky-opportunity